Integrated Molecular Analysis Reveals 2 Distinct Subtypes of Pure Seminoma of the Testis

Objective: Testicular germ cell tumors (TGCT) are the most common solid malignancy in adolescent and young men, with a rising incidence over the past 20 years. Overall, TGCTs are second in terms of the average life years lost per person dying of cancer, and clinical therapeutics without adverse long...

Full description

Bibliographic Details
Main Authors: Kirill E Medvedev, Anna V Savelyeva, Kenneth S Chen, Aditya Bagrodia, Liwei Jia, Nick V Grishin
Format: Article
Language:English
Published: SAGE Publishing 2022-10-01
Series:Cancer Informatics
Online Access:https://doi.org/10.1177/11769351221132634
_version_ 1811198803580026880
author Kirill E Medvedev
Anna V Savelyeva
Kenneth S Chen
Aditya Bagrodia
Liwei Jia
Nick V Grishin
author_facet Kirill E Medvedev
Anna V Savelyeva
Kenneth S Chen
Aditya Bagrodia
Liwei Jia
Nick V Grishin
author_sort Kirill E Medvedev
collection DOAJ
description Objective: Testicular germ cell tumors (TGCT) are the most common solid malignancy in adolescent and young men, with a rising incidence over the past 20 years. Overall, TGCTs are second in terms of the average life years lost per person dying of cancer, and clinical therapeutics without adverse long-term side effects are lacking. Platinum-based regimens for TGCTs have heterogeneous outcomes even within the same histotype that frequently leads to under- and over-treatment. Understanding of molecular differences that lead to diverse outcomes of TGCT patients may improve current treatment approaches. Seminoma is the most common subtype of TGCTs, which can either be pure or present in combination with other histotypes. Methods: Here we conducted a computational study of 64 pure seminoma samples from The Cancer Genome Atlas, applied consensus clustering approach to their transcriptomic data and revealed 2 clinically relevant seminoma subtypes: seminoma subtype 1 and 2. Results: Our analysis identified significant differences in pluripotency stage, activity of double stranded DNA breaks repair mechanisms, rates of loss of heterozygosity, and expression of lncRNA responsible for cisplatin resistance between the subtypes. Seminoma subtype 1 is characterized by higher pluripotency state, while subtype 2 showed attributes of reprograming into non-seminomatous TGCT. The seminoma subtypes we identified may provide a molecular underpinning for variable responses to chemotherapy and radiation. Conclusion: Translating our findings into clinical care may help improve risk stratification of seminoma, decrease overtreatment rates, and increase long-term quality of life for TGCT survivors.
first_indexed 2024-04-12T01:37:19Z
format Article
id doaj.art-751fd8a7bb3a49669b1093a57121bf76
institution Directory Open Access Journal
issn 1176-9351
language English
last_indexed 2024-04-12T01:37:19Z
publishDate 2022-10-01
publisher SAGE Publishing
record_format Article
series Cancer Informatics
spelling doaj.art-751fd8a7bb3a49669b1093a57121bf762022-12-22T03:53:17ZengSAGE PublishingCancer Informatics1176-93512022-10-012110.1177/11769351221132634Integrated Molecular Analysis Reveals 2 Distinct Subtypes of Pure Seminoma of the TestisKirill E Medvedev0Anna V Savelyeva1Kenneth S Chen2Aditya Bagrodia3Liwei Jia4Nick V Grishin5Department of Biophysics, University of Texas Southwestern Medical Center, Dallas, TX, USADepartment of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USAChildren’s Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, TX, USADepartment of Urology, University of California San Diego Health, La Jolla, CA, USADepartment of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, USADepartment of Biochemistry, University of Texas Southwestern Medical Center, Dallas, TX, USAObjective: Testicular germ cell tumors (TGCT) are the most common solid malignancy in adolescent and young men, with a rising incidence over the past 20 years. Overall, TGCTs are second in terms of the average life years lost per person dying of cancer, and clinical therapeutics without adverse long-term side effects are lacking. Platinum-based regimens for TGCTs have heterogeneous outcomes even within the same histotype that frequently leads to under- and over-treatment. Understanding of molecular differences that lead to diverse outcomes of TGCT patients may improve current treatment approaches. Seminoma is the most common subtype of TGCTs, which can either be pure or present in combination with other histotypes. Methods: Here we conducted a computational study of 64 pure seminoma samples from The Cancer Genome Atlas, applied consensus clustering approach to their transcriptomic data and revealed 2 clinically relevant seminoma subtypes: seminoma subtype 1 and 2. Results: Our analysis identified significant differences in pluripotency stage, activity of double stranded DNA breaks repair mechanisms, rates of loss of heterozygosity, and expression of lncRNA responsible for cisplatin resistance between the subtypes. Seminoma subtype 1 is characterized by higher pluripotency state, while subtype 2 showed attributes of reprograming into non-seminomatous TGCT. The seminoma subtypes we identified may provide a molecular underpinning for variable responses to chemotherapy and radiation. Conclusion: Translating our findings into clinical care may help improve risk stratification of seminoma, decrease overtreatment rates, and increase long-term quality of life for TGCT survivors.https://doi.org/10.1177/11769351221132634
spellingShingle Kirill E Medvedev
Anna V Savelyeva
Kenneth S Chen
Aditya Bagrodia
Liwei Jia
Nick V Grishin
Integrated Molecular Analysis Reveals 2 Distinct Subtypes of Pure Seminoma of the Testis
Cancer Informatics
title Integrated Molecular Analysis Reveals 2 Distinct Subtypes of Pure Seminoma of the Testis
title_full Integrated Molecular Analysis Reveals 2 Distinct Subtypes of Pure Seminoma of the Testis
title_fullStr Integrated Molecular Analysis Reveals 2 Distinct Subtypes of Pure Seminoma of the Testis
title_full_unstemmed Integrated Molecular Analysis Reveals 2 Distinct Subtypes of Pure Seminoma of the Testis
title_short Integrated Molecular Analysis Reveals 2 Distinct Subtypes of Pure Seminoma of the Testis
title_sort integrated molecular analysis reveals 2 distinct subtypes of pure seminoma of the testis
url https://doi.org/10.1177/11769351221132634
work_keys_str_mv AT kirillemedvedev integratedmolecularanalysisreveals2distinctsubtypesofpureseminomaofthetestis
AT annavsavelyeva integratedmolecularanalysisreveals2distinctsubtypesofpureseminomaofthetestis
AT kennethschen integratedmolecularanalysisreveals2distinctsubtypesofpureseminomaofthetestis
AT adityabagrodia integratedmolecularanalysisreveals2distinctsubtypesofpureseminomaofthetestis
AT liweijia integratedmolecularanalysisreveals2distinctsubtypesofpureseminomaofthetestis
AT nickvgrishin integratedmolecularanalysisreveals2distinctsubtypesofpureseminomaofthetestis